Forecast: Re-Import of Heparin for Therapeutic Use to Canada

In 2023, Canada's re-importation of heparin for therapeutic use stood at approximately 2.014 million USD. The forecast data from 2024 shows a steady increase in the value, with annual variations indicating an upward trend. The year-on-year percentage change for 2024 to 2025 is projected at around 6.4%, from 2025 to 2026 at about 5.9%, with subsequent years showing similar steady growth patterns. The compound annual growth rate (CAGR) from 2024 to 2028 is expected to be approximately 5.7%, indicating consistent growth in demand and value.

Future trends to watch include potential impacts of regulatory changes, advancements in alternative therapies, and fluctuations in global heparin supply chains, which may influence Canada's import patterns and values. Monitoring these factors will be crucial for stakeholders in the healthcare and import sectors.